Impact of KRAS codon subtypes from a randomised phase II trial of selumetinib plus docetaxel in KRAS mutant advanced non-small-cell lung cancer - Concepedia

Concepedia

Publication | Open Access

Impact of KRAS codon subtypes from a randomised phase II trial of selumetinib plus docetaxel in KRAS mutant advanced non-small-cell lung cancer

DOI Full Paper Access

74

Citations

8

References

2015

Year

Pasi A. Jänne, Ian C. P. Smith, Gael McWalter, Helen Mann, Brian Dougherty, Jill Walker, Maria Orr, Darren Hodgson, Alice T. Shaw, José Rodrigues Pereira,

British Journal of Cancer

References

	Year	Citations

Page 1